A
Avience Biomedicals Ltd.
SMEListedListed on 25 Jun 2026+90.0%
Price Range
₹196–208
Issue Size
₹ 22 Cr
Lot Size
1200 Shares
Min. Investment
₹ 2,35,200
Historical Financials
Annual consolidated / standalone figures
| Particulars | FY 2023-24 | FY 2024-25 |
|---|---|---|
| Operating Revenue (₹ Cr) | 2,396.4 | 4,523.6 |
| Other Income (₹ Cr) | 40.86 | 73.15 |
| Total Income (₹ Cr) | 2,437.26 | 4,596.75 |
| Total Expenses (₹ Cr) | 1,985.99 | 3,378.8 |
| Profit Before Tax (₹ Cr) | 295.86 | 980.07 |
| PAT (₹ Cr) | 215.16 | 723.18 |
| Net Worth (₹ Cr) | 622.76 | 2,277.72 |
| Borrowings (₹ Cr) | 0 | 0 |
| EPS (₹) | 6.55 | 19.06 |
| ROE (%) | 34.55 | 49.9 |